Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women.
about
The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysisPrevalence of proteinuria among HIV-infected children attending a tertiary hospital in Lagos, Nigeria.HIV-infected persons continue to lose kidney function despite successful antiretroviral therapyThe association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men.Hospitalizations in a cohort of HIV patients in Australia, 1999-2007Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use?Prevalence and risk factors associated to chronic kidney disease in HIV-infected patients on HAART and undetectable viral load in BrazilWHO antiretroviral therapy guidelines 2010 and impact of tenofovir on chronic kidney disease in Vietnamese HIV-infected patients.Strong correlation between protein reagent strip and protein-to-creatinine ratio for detection of renal dysfunction in HIV-infected patients: a cross-sectional studyMicroalbuminuria in HIV infection.Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individualsCardiovascular Disease in Blacks with HIV/AIDS in the United States: A Systematic Review of the LiteratureThe association between the receipt of lipid lowering therapy and HIV status among veterans who met NCEP/ATP III criteria for the receipt of lipid lowering medicationAlbuminuria as a marker of cardiovascular risk in HIV-infected individuals receiving stable antiretroviral therapy.Hospitalizations for cardiovascular disease in African Americans and whites with HIV/AIDS.The impact of disease stage on direct medical costs of HIV management: a review of the international literature.Healthcare utilization and direct costs of non-infectious comorbidities in HIV-infected patients in the USA.Modelling the budget impact of darunavir in the treatment of highly treatment-experienced, HIV-infected adults in France.Estimation of glomerular filtration rate by using serum cystatin C and serum creatinine concentrations in patients with human immunodeficiency virus.Tenofovir nephrotoxicity: focusing research questions and putting them into clinical context.Trends in hospitalizations with psychiatric diagnoses among HIV-infected women in the USA, 1994-2004.
P2860
Q27489415-8B61844D-3BC1-4F1D-BD33-43857058DB71Q30381197-BC51B481-D7E1-4F3C-9B37-64DA2BA3DFF9Q33731258-43DE3E0E-C580-410B-A9DD-458CE051089DQ33807791-9127F54E-4373-46FC-ABD1-EAAC2C253D4FQ33924662-56097F90-D43E-4BE8-BA71-6E917748F7A0Q34027867-8C0D421E-11DB-4DCA-8860-7FB5D4B78A7EQ34055914-6EDD9502-DE7C-432A-9EF3-B665D9D8529DQ35040358-C07CEE26-E2B9-4050-9736-38E58FB06D61Q35201114-6301C709-5A5C-4D53-A1D3-6EE59989BCEEQ35293817-BF9B7D4E-EA38-4234-9E1E-AB6701F5EC08Q35604023-6DF0A547-08C8-4109-B833-EBFA99FF0051Q35652711-73E05394-A352-4451-A3B0-1B8E79862919Q35931698-FF6DEE9F-F606-492C-9F5E-0AE858902333Q37096897-CAA560FD-4C68-4827-9B8B-E063BD70B806Q37150657-B649FAE5-4514-42BC-89C5-4EEFA8E3F320Q37342807-02EC0D63-99C4-4DEA-98D0-5E9E82A1D81CQ37823559-824C053E-C5E9-457F-A24C-0F1536BBAFECQ41995759-DF41335A-BF96-4D94-A57E-3DD656F4C5FDQ42772425-CF61F7FB-8851-4FAF-91C5-26A1C0B41610Q42875455-45A1BAC3-3D8A-4323-AC6F-B127F19657E4Q46826166-26617D24-CF8E-4143-BFE5-0EBFFA35D658Q47294800-88114A65-CDA3-4259-A470-8185DE39577C
P2860
Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Rates and risk factors for con ...... infected and uninfected women.
@en
Rates and risk factors for con ...... infected and uninfected women.
@nl
type
label
Rates and risk factors for con ...... infected and uninfected women.
@en
Rates and risk factors for con ...... infected and uninfected women.
@nl
prefLabel
Rates and risk factors for con ...... infected and uninfected women.
@en
Rates and risk factors for con ...... infected and uninfected women.
@nl
P2093
P1476
Rates and risk factors for con ...... infected and uninfected women.
@en
P2093
Alan Greenberg
Anne M Rompalo
HIV Epidemiology Research Study Group
Karen Tashima
Lynda A Szczech
Paula Schuman
Ramses F Sadek
Robert S Klein
Ruby M Phelps
Scott D Holmberg
P304
P356
10.1097/00126334-200311010-00011
P407
P577
2003-11-01T00:00:00Z